Pernille Grue

Pernille Grue is a Principal Scientist at LEO Pharma since May 2022, bringing over 15 years of expertise in bioanalytical assay validation for pharmacokinetic/toxicokinetic and biomarker assays in compliance with FDA and EMA guidelines. Prior experience includes roles as Senior Scientist at Unilabs (formerly Capio Diagnostik) from 2007 to 2021, and Scientist at Capio Diagnostik from 2004 to 2007, where responsibilities included validating ADA assays and conducting stability studies. Earlier career highlights include positions as a Scientific Researcher at The Department of Clinical Biochemistry at Rigshospitalet and the Dairy- and Food Science Institute, and a Laboratory Research Assistant at Statens Serum Institut, focusing on ELISA assays and biochemical research. Pernille Grue holds a PhD in Biology from The Julius Maximilians University of Würzburg and a Cand. Scient in Biochemistry from the University of Copenhagen.